{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:20:09Z","timestamp":1720311609868},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,6]]},"DOI":"10.7759\/cureus.63978","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:06:37Z","timestamp":1720281997000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Hepatitis B Virus Reactivation With a Combination of Entecavir and Short-Term Administration of Interferon-\u03b2 Twice per Day"],"prefix":"10.7759","author":[{"given":"Kyo","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Suetsugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Yabushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosaku","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90599-g","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study","volume":"100","author":"Lok AS","year":"1991","unstructured":"Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology. 1991, 100:182-8. 10.1016\/0016-5085(91)90599-g","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab","volume":"344","author":"Dervite I","year":"2001","unstructured":"Dervite I, Hober D, Morel P. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med. 2001, 344:68-9. 10.1056\/NEJM200101043440120","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy","volume":"131","author":"Hui CK","year":"2006","unstructured":"Hui CK, Cheung WW, Zhang HY, et al.. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology. 2006, 131:59-68. 10.1053\/j.gastro.2006.04.015","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo W","year":"2009","unstructured":"Yeo W, Chan TC, Leung NW, et al.. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol. 2009, 27:605-11. 10.1200\/JCO.2008.18.0182","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15704","article-title":"Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial","volume":"312","author":"Huang H","year":"2014","unstructured":"Huang H, Li X, Zhu J, et al.. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial. JAMA. 2014, 312:2521-30. 10.1001\/jama.2014.15704","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/590968","article-title":"Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan","volume":"47","author":"Umemura T","year":"2008","unstructured":"Umemura T, Tanaka E, Kiyosawa K, Kumada H. Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. Clin Infect Dis. 2008, 47:e52-6. 10.1086\/590968","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","unstructured":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017, 67.370-98. 10.1016\/j.jhep.2017.03.021","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13504","article-title":"Japan Society of Hepatology Guidelines for the Management of Hepatitis\u00a0B Virus Infection: 2019 update","volume":"50","year":"2020","unstructured":"Japan Society of Hepatology Guidelines for the Management of Hepatitis\u00a0B Virus Infection. 2019 update. Hepatol Res. 2020, 50:892-923. 10.1111\/hepr.13504","journal-title":"Hepatol Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2011.00860.x","article-title":"Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan","volume":"41","author":"Mochida S","year":"2011","unstructured":"Mochida S, Takikawa Y, Nakayama N, et al.. Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res. 2011, 41:805-12. 10.1111\/j.1872-034X.2011.00860.x","journal-title":"Hepatol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.081935","article-title":"Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial","volume":"55","author":"Enomoto M","year":"2006","unstructured":"Enomoto M, Tamori A, Kawada N, et al.. Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial. Gut. 2006, 55:139-40. 10.1136\/gut.2005.081935","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2014.04.009","article-title":"Interferon-beta plus ribavirin therapy can be safely and effectively administered to elderly patients with chronic hepatitis C","volume":"20","author":"Nomura H","year":"2014","unstructured":"Nomura H, Miyagi Y, Tanimoto H, Yamashita N. Interferon-beta plus ribavirin therapy can be safely and effectively administered to elderly patients with chronic hepatitis C. J Infect Chemother. 2014, 20:489-92. 10.1016\/j.jiac.2014.04.009","journal-title":"J Infect Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2011.00930.x","article-title":"Occurrence of clinical depression during combination therapy with pegylated interferon alpha or natural human interferon beta plus ribavirin","volume":"42","author":"Nomura H","year":"2012","unstructured":"Nomura H, Miyagi Y, Tanimoto H, Yamashita N, Oohashi S, Nishiura S. Occurrence of clinical depression during combination therapy with pegylated interferon alpha or natural human interferon beta plus ribavirin. Hepatol Res. 2012, 42:241-7. 10.1111\/j.1872-034X.2011.00930.x","journal-title":"Hepatol Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2012.07171.x","article-title":"Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy","volume":"27","author":"Nomura H","year":"2012","unstructured":"Nomura H, Miyagi Y, Tanimoto H, Yamashita N, Ito K, Masaki N, Mizokami M. Increase in platelet count based on inosine triphosphatase genotype during interferon beta plus ribavirin combination therapy. J Gastroenterol Hepatol. 2012, 27:1461-6. 10.1111\/j.1440-1746.2012.07171.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26086","article-title":"A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta","volume":"34","author":"Asahina Y","year":"2001","unstructured":"Asahina Y, Izumi N, Uchihara M, et al.. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta. Hepatology. 2001, 34:377-84. 10.1053\/jhep.2001.26086","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91082-s","article-title":"Long-term follow-up of chronic hepatitis B patients treated with interferon alfa","volume":"105","author":"Lok AS","year":"1993","unstructured":"Lok AS, Chung HT, Liu VW, Ma OC. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology. 1993, 105:1833-8. 10.1016\/0016-5085(93)91082-s","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00450.x","article-title":"Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"10","author":"Cooksley WG","year":"2003","unstructured":"Cooksley WG, Piratvisuth T, Lee SD, et al.. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. J Viral Hepat. 2003, 10:298-305. 10.1046\/j.1365-2893.2003.00450.x","journal-title":"J Viral Hepat"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043470","article-title":"Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B","volume":"352","author":"Lau GK","year":"2005","unstructured":"Lau GK, Piratvisuth T, Luo KX, et al.. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med. 2005, 352:2682-95. 10.1056\/NEJMoa043470","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.3038","article-title":"Short-term intravenous interferon therapy for chronic hepatitis B","volume":"14","author":"Okushin H","year":"2008","unstructured":"Okushin H, Ohnishi T, Morii K, Uesaka K, Yuasa S. Short-term intravenous interferon therapy for chronic hepatitis B. World J Gastroenterol. 2008, 14:3038-43. 10.3748\/wjg.14.3038","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2014.0234","article-title":"Long-term outcome of sequential therapy with lamivudine followed by interferon-\u03b2 in nucleoside-naive, hepatitis B e-antigen-positive patients with chronic hepatitis B virus genotype C infection","volume":"35","author":"Enomoto M","year":"2015","unstructured":"Enomoto M, Nishiguchi S, Tamori A, et al.. Long-term outcome of sequential therapy with lamivudine followed by interferon-\u03b2 in nucleoside-naive, hepatitis B e-antigen-positive patients with chronic hepatitis B virus genotype C infection. J Interferon Cytokine Res. 2015, 35:613-20. 10.1089\/jir.2014.0234","journal-title":"J Interferon Cytokine Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2012.01077.x","article-title":"Case treated with triple therapy of lamivudine, interferon-\u03b2 and prednisolone for acute exacerbation of chronic hepatitis B during pregnancy","volume":"43","author":"Koh M","year":"2013","unstructured":"Koh M, Shinohara J, Hongo Y, Okazaki T, Takitani K, Tamai H. Case treated with triple therapy of lamivudine, interferon-\u03b2 and prednisolone for acute exacerbation of chronic hepatitis B during pregnancy. Hepatol Res. 2013, 43:425-9. 10.1111\/j.1872-034X.2012.01077.x","journal-title":"Hepatol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/263340-successful-treatment-of-hepatitis-b-virus-reactivation-with-a-combination-of-entecavir-and-short-term-administration-of-interferon--twice-per-day","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:06:40Z","timestamp":1720282000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/263340-successful-treatment-of-hepatitis-b-virus-reactivation-with-a-combination-of-entecavir-and-short-term-administration-of-interferon--twice-per-day"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.63978","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,6]]}}}